JOYN Advisors’s Kyntra Bio KYNB Stock Holding History

JOYN Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-102	Closed	-$118K	–	558
2018 Q4	$118K	Buy	+102	New	+$115K	0.03%	172

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

JOYN Advisors's KYNB Position: Q1 2019 in Review

JOYN Advisors sold out of Kyntra Bio (KYNB) in Q1 2019, closing a stake of 102 shares — an estimated $118K sold.

JOYN Advisors first reported a position in KYNB in Q4 2018 and held it in 1 quarter. The position peaked at $118K in Q4 2018. 225 funds tracked by Wall St. Rank hold KYNB as of Q1 2019.

JOYN Advisors reported no remaining Kyntra Bio position as of Q1 2019 after selling out during the quarter.
JOYN Advisors sold 102 Kyntra Bio shares in Q1 2019, an estimated $118K.
JOYN Advisors first reported a position in Kyntra Bio in Q4 2018 and held it in 1 quarter.
JOYN Advisors's Kyntra Bio position peaked at $118K in Q4 2018.
225 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.